Loading clinical trials...
Loading clinical trials...
The purpose of this research study is to test the combination of the anti-cancer drugs durvalumab, the study drug, and cetuximab as a treatment for metastatic or recurrent head and neck cancer. Partic...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Trisha Wise-Draper
Collaborators
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
NCT06477692 · Head and Neck Cancer
UC Health
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions